Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Fundamental data now powered by FactSet with hourly updates!

ERAS | Erasca Inc

IndexRUT P/E- EPS (ttm)-1.79 Insider Own38.70% Shs Outstand149.33M Perf Week-12.03%
Market Cap320.20M Forward P/E- EPS next Y-1.13 Insider Trans0.38% Shs Float92.60M Perf Month-19.08%
Income-235.72M PEG- EPS next Q-0.24 Inst Own41.54% Short Float / Ratio9.63% / 17.51 Perf Quarter-17.83%
Sales0.00M P/S- EPS this Y49.60% Inst Trans3.06% Short Interest8.92M Perf Half Y-24.01%
Book/sh2.41 P/B0.88 EPS next Y-12.86% ROA-53.24% Target Price14.50 Perf Year-72.03%
Cash/sh2.10 P/C1.01 EPS next 5Y- ROE-62.21% 52W Range2.11 - 9.25 Perf YTD-50.81%
Dividend- P/FCF- EPS past 5Y- ROI-56.57% 52W High-77.08% Beta1.14
Dividend %- Quick Ratio13.90 Sales past 5Y0.00% Gross Margin- 52W Low0.47% ATR0.14
Employees129 Current Ratio13.90 Sales Q/Q- Oper. Margin0.00% RSI (14)26.54 Volatility7.36% 5.06%
OptionableYes Debt/Eq0.16 EPS Q/Q28.49% Profit Margin- Rel Volume0.87 Prev Close2.12
ShortableYes LT Debt/Eq0.15 EarningsAug 10 AMC Payout- Avg Volume509.51K Price2.12
Recom1.00 SMA20-15.75% SMA50-17.46% SMA200-33.41% Volume445,714 Change0.00%
Date Action Analyst Rating Change Price Target Change
Mar-30-23Initiated Mizuho Buy $9
Feb-24-23Initiated Goldman Buy $10
Feb-03-23Upgrade Morgan Stanley Equal-Weight → Overweight $15
Sep-19-23 08:00AM
Sep-05-23 08:00AM
Aug-29-23 08:00AM
Aug-10-23 04:01PM
Jul-12-23 06:35AM
04:01PM Loading…
Jun-22-23 04:01PM
Jun-15-23 06:22AM
Jun-06-23 10:53AM
Jun-05-23 04:01PM
Jun-01-23 08:00AM
May-31-23 08:00AM
May-25-23 05:00PM
May-16-23 08:00AM
May-15-23 04:01PM
08:00AM Loading…
May-02-23 08:00AM
May-01-23 08:00AM
Apr-26-23 05:00PM
Apr-25-23 08:00AM
Apr-18-23 09:00AM
Apr-12-23 07:07AM
Apr-10-23 08:00AM
Mar-31-23 06:19AM
Mar-30-23 04:21AM
Mar-23-23 04:01PM
Mar-14-23 04:31PM
Feb-01-23 08:00AM
Jan-16-23 06:19AM
Jan-11-23 03:04PM
Jan-04-23 08:00AM
08:00AM Loading…
Dec-20-22 08:00AM
Dec-17-22 07:28AM
Dec-16-22 07:15AM
Dec-13-22 08:00AM
Dec-09-22 10:00AM
Nov-30-22 08:00AM
Nov-22-22 08:00AM
Nov-14-22 09:55AM
Nov-09-22 04:01PM
Oct-20-22 08:00AM
Oct-12-22 08:00AM
Sep-26-22 08:00AM
Sep-09-22 08:31AM
Sep-08-22 11:08AM
Sep-07-22 04:05PM
Aug-24-22 08:00AM
Aug-23-22 09:55AM
Aug-19-22 09:55AM
Aug-11-22 04:05PM
Aug-08-22 09:29AM
Aug-03-22 09:55AM
Jul-27-22 06:00PM
Jul-21-22 06:00PM
Jul-18-22 06:15PM
Jul-12-22 06:00PM
Jul-06-22 06:15PM
Jun-09-22 09:55AM
Jun-03-22 09:00AM
Jun-02-22 08:00AM
May-25-22 08:00AM
May-23-22 09:55AM
May-12-22 04:01PM
May-03-22 08:00AM
Apr-27-22 08:00AM
Apr-15-22 07:42AM
Apr-12-22 04:01PM
Apr-06-22 08:00AM
Mar-24-22 04:05PM
Mar-10-22 08:00AM
Mar-08-22 04:31PM
Mar-01-22 04:14PM
Feb-08-22 09:04AM
Feb-03-22 08:00AM
Jan-27-22 01:38PM
Jan-18-22 08:00AM
Jan-04-22 08:00AM
Dec-24-21 12:38AM
Dec-18-21 12:38AM
Dec-17-21 08:00AM
Dec-16-21 09:38AM
Dec-15-21 05:46AM
Dec-14-21 08:00AM
Dec-11-21 05:38AM
Nov-16-21 08:00AM
Nov-10-21 04:05PM
Oct-25-21 04:01PM
Oct-16-21 09:45AM
Erasca, Inc. is a clinical stage precision oncology company, It focuses on discovering, developing, and commercializing therapies for RAS/MAPK pathway-driven cancers. It has assembled a wholly owned or controlled RAS/MAPK pathway focused pipeline comprising modality-agnostic programs. The company was founded by Jonathan E. Lim on July 2, 2018 and is headquartered in San Diego, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Lim Jonathan EChairman & CEOJun 08Buy2.75100,000275,00018,396,216Jun 08 08:54 PM
Casdin Alexander W.DirectorApr 10Buy2.7620,00055,230463,974Apr 11 08:23 AM
Lim Jonathan EChairman & CEOMar 28Buy2.84100,000284,00018,296,216Mar 28 09:24 PM
Lim Jonathan EChairman & CEOJan 10Buy3.8660,000231,42020,256,222Jan 10 04:46 PM
Bristol James ArthurDirectorDec 21Buy4.1420,00082,80020,000Dec 22 09:26 PM
Start Valerie Denise HardingDirectorDec 21Buy4.6410,00046,40010,000Dec 22 09:28 PM
Casdin Alexander W.DirectorDec 15Buy4.8720,00097,490443,974Dec 15 04:47 PM
Lim Jonathan EChairman & CEODec 14Buy4.9940,000199,60020,196,222Dec 15 11:53 AM
Chen BihuaDirectorDec 13Buy6.50307,6921,999,99810,813,246Dec 20 05:42 PM